TSH Biopharm (ROCO:8432) Institutional Ownership: 0.37% (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8432 TSH Biopharm Corp Ltd ROCO:8432
87 GF Score
Price NT$50.00
GF Value NT$71.26
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is TSH Biopharm Institutional Ownership?

TSH Biopharm ROCO:8432 -1.78% 87 Institutional Ownership is 0.37% as of Aug. 19, 2026. GuruFocus rates ROCO:8432 with a GF Score™ of 87/100 and a GF Value™ of NT$71.26 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TSH Biopharm's institutional ownership is 0.37%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TSH Biopharm's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TSH Biopharm's Float Percentage Of Total Shares Outstanding is 0.00%.

TSH Biopharm Institutional Ownership Historical Data

* Premium members only.

The historical data trend for TSH Biopharm's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TSH Biopharm Institutional Ownership Chart

TSH Biopharm Historical Data

The historical data trend for TSH Biopharm can be seen below:

2016-09-30 2016-10-31 2016-11-30 2016-12-31 2017-01-31 2017-02-28 2017-03-31 2017-04-30 2017-05-31 2017-06-30
Institutional Ownership 0.53 0.53 0.53 0.53 0.37 0.37 0.37 0.37 0.37 0.37
ROCO:8432
87GF Score
TSH Biopharm Corp Ltd ROCO:8432
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TSH Biopharm Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.37% mean?
TSH Biopharm (ROCO:8432) has a Institutional Ownership of 0.37% as of Aug. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TSH Biopharm and its competitors.
Is TSH Biopharm's Institutional Ownership too high?
TSH Biopharm's current Institutional Ownership is 0.37%. Overall, TSH Biopharm has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TSH Biopharm's Institutional Ownership compare to ZTS?
TSH Biopharm's Institutional Ownership of 0.37% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TSH Biopharm and its competitors. TSH Biopharm's current Institutional Ownership is 0.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TSH Biopharm stock overvalued right now?
Based on GuruFocus' analysis, TSH Biopharm (ROCO:8432) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$71.26, compared to a current price of NT$50.00 — trading 29.8% below its estimated fair value. The current Institutional Ownership is 0.37%. TSH Biopharm's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For TSH Biopharm (ROCO:8432), the current Institutional Ownership is 0.37% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TSH Biopharm (ROCO:8432) Overvalued in 2026?

Based on GuruFocus' analysis, TSH Biopharm stock appears to be undervalued. The current stock price of NT$50.00 is trading 29.8% below its estimated GF Value™ of NT$71.26. GuruFocus considers TSH Biopharm to be Significantly Undervalued.

Key valuation signals for ROCO:8432:

  • Institutional Ownership: 0.37%
  • GF Value™: NT$71.26 vs. price of NT$50.00 (29.8% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the ROCO:8432 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TSH Biopharm Business Description

Address No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
TSH Biopharm Corp Ltd is engaged in sale of a variety of pharmaceuticals, chemical drugs and engaged in biotechnology services. The company specializes in the development, manufacture, and marketing of branded drugs for chronic diseases. Key therapeutic areas include cardiovascular, central nervous system, gastroenterology, and severe chronic diseases, alongside precision medicine/genetic testing services .The Company's revenue is earned domestically. It earns majority of its revenue from the sale of Lozenges.
87GF Score

Get the complete analysis for ROCO:8432

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.00
Price
NT$71.26
GF Value